Menu
30/10/2013
Queen's Joins Cystic Fibrosis Research Programme
Scientists at Queen's University Belfast are taking part in a new €6m bid to find treatments for Cystic Fibrosis.
Professor Stuart Elborn will lead the study at Queen's University, which is the lead partner in the new research programme.
Affecting more than 10,000 people in the UK, Cystic Fibrosis (CF) is one of the most common life-threatening inherited diseases.
The new global programme, known as CF Matters, aims to develop personalised antibiotic treatments for the chest infections that are commonly caused by the disease.
The study brings together renowned CF clinicians and scientists from 12 academic institutions and hospitals across Europe and the USA.
It is led by University College Cork with Queen’s as a lead partner. It will involve lab-based research and clinical trials with 252 patients in seven countries, including around 40 in Northern Ireland.
Queen's lead on the study is Professor Stuart Elborn, Director of Queen's Centre for Infection and Immunity.
He said: "When patients have a flare-up they are treated with several antibiotics but it isn’t always effective and can lead to antibiotic resistance. In this study we will use molecular next generation DNA sequencing methods to detect all the bacteria present in the sputum of CF patients and use this knowledge to determine what antibiotics should be used in individual patients.
"This personalised antibiotic treatment will be compared with standard therapy for CF patients. We will determine the patient’s immune response to all the different bacteria present in the sputum. Using models of infection we will also discover the effect of these bacteria on lung inflammation and infection. The overall impact will be to determine if all bacteria present contribute significantly to lung infection in CF patients and subsequently identify the most effective antibiotic treatment for patients infected with these bacteria."
The study will involve a team of scientists from Queen's Centre for Infection and Immunity including Professor Cliff Taggart, Dr Rebecca Ingram and Dr Sinéad Weldon and Dr Michael Tunney from the School of Pharmacy.
(IT/CD)
Professor Stuart Elborn will lead the study at Queen's University, which is the lead partner in the new research programme.
Affecting more than 10,000 people in the UK, Cystic Fibrosis (CF) is one of the most common life-threatening inherited diseases.
The new global programme, known as CF Matters, aims to develop personalised antibiotic treatments for the chest infections that are commonly caused by the disease.
The study brings together renowned CF clinicians and scientists from 12 academic institutions and hospitals across Europe and the USA.
It is led by University College Cork with Queen’s as a lead partner. It will involve lab-based research and clinical trials with 252 patients in seven countries, including around 40 in Northern Ireland.
Queen's lead on the study is Professor Stuart Elborn, Director of Queen's Centre for Infection and Immunity.
He said: "When patients have a flare-up they are treated with several antibiotics but it isn’t always effective and can lead to antibiotic resistance. In this study we will use molecular next generation DNA sequencing methods to detect all the bacteria present in the sputum of CF patients and use this knowledge to determine what antibiotics should be used in individual patients.
"This personalised antibiotic treatment will be compared with standard therapy for CF patients. We will determine the patient’s immune response to all the different bacteria present in the sputum. Using models of infection we will also discover the effect of these bacteria on lung inflammation and infection. The overall impact will be to determine if all bacteria present contribute significantly to lung infection in CF patients and subsequently identify the most effective antibiotic treatment for patients infected with these bacteria."
The study will involve a team of scientists from Queen's Centre for Infection and Immunity including Professor Cliff Taggart, Dr Rebecca Ingram and Dr Sinéad Weldon and Dr Michael Tunney from the School of Pharmacy.
(IT/CD)
Related Northern Ireland News Stories
Click here for the latest headlines.
15 March 2022
Over 1,700 Patients Receiving Ground-Breaking Covid-19 Treatments
More than 1,700 patients at highest risk of serious illness across NI have received ground-breaking Covid-19 treatments. The patients have received neutralising monoclonal antibody (nMAB) and antiviral treatments at Health and Social Care (HSC) Trust Outpatient COVID-19 Treatment services (OCTs), or oral antiviral medicine to take at home.
Over 1,700 Patients Receiving Ground-Breaking Covid-19 Treatments
More than 1,700 patients at highest risk of serious illness across NI have received ground-breaking Covid-19 treatments. The patients have received neutralising monoclonal antibody (nMAB) and antiviral treatments at Health and Social Care (HSC) Trust Outpatient COVID-19 Treatment services (OCTs), or oral antiviral medicine to take at home.
15 June 2021
Health Minister Applauds Vaccination Take-Up Initiatives
Initiatives to support vaccination take-up have been applauded by Health Minister Robin Swann. A targeted programme of pop-up clinics is being rolled out to different locations in Northern Ireland, helping local communities access vaccines.
Health Minister Applauds Vaccination Take-Up Initiatives
Initiatives to support vaccination take-up have been applauded by Health Minister Robin Swann. A targeted programme of pop-up clinics is being rolled out to different locations in Northern Ireland, helping local communities access vaccines.
22 May 2017
Concerns Raised Over Adult Mental Health Patients
The number of adult mental health patients waiting longer than nine weeks to access key services has more than doubled from 338 in March 2016 to over 800 in March 2017, according to new figures. Ulster Unionist Mental Health spokesperson, Robbie Butler MLA, warned that mental health patients could be coming to harm.
Concerns Raised Over Adult Mental Health Patients
The number of adult mental health patients waiting longer than nine weeks to access key services has more than doubled from 338 in March 2016 to over 800 in March 2017, according to new figures. Ulster Unionist Mental Health spokesperson, Robbie Butler MLA, warned that mental health patients could be coming to harm.
31 March 2011
NI Misses Cancer Treatment Targets
Northern Ireland's hospitals have failed to meet target times for the treatment of patients referred for suspected cancer, a new report by the Department of Health revealed. Its guidelines say 95% of patients should begin their treatment within 62 days. Last December however, the figure stood at 81%, which was the third monthly fall in a row.
NI Misses Cancer Treatment Targets
Northern Ireland's hospitals have failed to meet target times for the treatment of patients referred for suspected cancer, a new report by the Department of Health revealed. Its guidelines say 95% of patients should begin their treatment within 62 days. Last December however, the figure stood at 81%, which was the third monthly fall in a row.
24 May 2010
NI Doctors Say 'Half Of Them Attacked'
Violence and abuse against doctors is a problem and on the rise, according to a report published by the British Medical Association in Northern Ireland (BMA(NI)) today.
NI Doctors Say 'Half Of Them Attacked'
Violence and abuse against doctors is a problem and on the rise, according to a report published by the British Medical Association in Northern Ireland (BMA(NI)) today.
-
Northern Ireland WeatherThis Evening and Tonight:Rain clearing away east by early evening with some clear spells but a few showers likely to affect the North coast and other areas towards dawn, remaining breezy and mild overnight. Minimum temperature 9 °C.
